| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 138,825 | 165,540 | 124,915 | | Cost of Revenue | 58,110 | 71,099 | 56,772 | | | Gross Profit | 80,715 | 94,441 | 68,143 | | | Operating Expenses | | Research Development | 37,424 | 34,624 | 31,751 | | Selling General and Administrative | 39,003 | 34,712 | 29,995 | | Non Recurring | 3,724 | 1,484 | 10,962 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 564 | 23,621 | (4,565) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (12,133) | 2,819 | 2,858 | | Earnings Before Interest And Taxes | (11,569) | 26,440 | (1,707) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (11,569) | 26,440 | (1,707) | | Income Tax Expense | 2,240 | 1,456 | (2,450) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,809) | 24,984 | 743 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (13,809) | 24,984 | 743 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,809) | $24,984 | $743 |
|
0.02% Nasdaq 0.00%
Income Statement
